Copyright © 2018 Claristock. All Right Reserved
Total Mark
85
Above 70 is preferred
Stock Analysis
| Growth Potential | 94 | |
|---|---|---|
| Profitability | 87 | |
| Financial Strength | 86 | |
| Q3 2020 Result | 94 | |
| Q2 2020 Result | 50 | |
| Result 2019 | 59 |
Growth Estimate
| 21 Estimate | 22 Estimate | |
|---|---|---|
| Revenue Growth (%) | 26.5 | 26.1 |
| EPS Growth (%) | 16.1 | 37.6 |
| ROE (%) | 21.6 | 25.6 |
| P/E (times) | ... | ... |
Market Analysis
| Market Sentiment | 75 | |
|---|---|---|
| Relative Valuation | 33 | |
| Being a Value Stock | 70 | |
| Absolute Valuation | 18 |
For more detailed information about Horizon Therapeutics Plc, please go to Yahoo Finance